The Danish Chamber of Commerce in Japan is thrilled to welcome Genmab K.K. as our newest Corporate Member. Genmab is an international biotech company committed to the goal of improving the lives of patients through innovative and differentiated antibody therapeutics.
A Global Pioneer in Antibody-Based Therapies
Genmab is an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases. For 25 years, the company's passionate, innovative, and collaborative team has developed next-generation antibody technology platforms and leveraged translational, quantitative, and data sciences. This has led to a proprietary pipeline that includes bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector-function-enhanced antibodies.
Founded in 1999 and headquartered in Copenhagen, Denmark, Genmab has expanded its reach across North America, Europe, and Asia Pacific, building a strong international presence.
By 2030, the company’s vision is to transform the lives of people with cancer and other serious diseases through its groundbreaking KYSO® antibody medicines.
A Strong Presence in Japan
Genmab K.K. plays a pivotal role in advancing the company’s global mission, delivering life-changing therapies to patients across Japan and Asia Pacific. The company works closely with local medical and scientific communities, ensuring its research and development efforts contribute to Japan’s dynamic and rapidly evolving biotech sector.
Embracing Innovation and Collaboration
At Genmab, employees are empowered to be authentically themselves—innovating, building solutions, and executing ideas while feeling supported and cared for. This collaborative, dynamic environment makes working at Genmab an extra[not]ordinary™ experience.
Known for its warm, inclusive workplace, Genmab encourages innovation, teamwork, and the execution of bold ideas. Guided by core values of passion for innovation, determination, integrity, and mutual respect, Genmab continues to deliver transformative outcomes for patients worldwide.
Looking Ahead
As Genmab continues to expand its global footprint and make significant strides in biotechnology, its focus remains firmly on its mission: to transform healthcare through breakthrough antibody medicines.
The Danish Chamber of Commerce in Japan is excited to support Genmab as they continue to innovate and create a lasting impact on the global biotech landscape. We look forward to witnessing Genmab K.K.'s continued success in Japan and beyond.
For more information, visit Genmab.com, or follow the company on LinkedIn or X.